Correction: Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease: real-world evidence from a German University Hospital
Front Endocrinol (Lausanne). 2026 Oct 5;17:1954561. doi: 10.3389/fendo.2026.1954561. eCollection 2026.ABSTRACT[This corrects the article DOI: 10.3389/fendo.2025.1736984.].PMID:42898842 | PMC:PMC13679133 | DOI:10.3389/fendo.2026.1954561

